Hard-to-treat Myc-Driven Cancers May Be Susceptible To Drug Already Used In Clinic

The mTORC1 inhibitor everolimus is used to treat various medical conditions. Everolimus prevented disease development in a mouse model of Myc-driven lymphoma. Treatment led to tumor regression in mice by inducing cellular senescence... via Health News from Medical News Today Read More Here..